Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Microscope in a BioEscalator Lab


Alchemab announced as finalists for OBN Awards 2020

Novel therapeutics company, Alchemab Therapeutics, has been shortlisted in the Best Start-Up category of the 12th Annual OBN Awards.

Alchemab collaborate with leading AI institute to advance drug discovery

BioEscalator residents Alchemab Therapeutics announce partnership the Alberta Machine Intelligence Institute (Amii), a global leader in machine intelligence.

Oncology expert Carsten Reinhardt joins Theolytics Board of Directors

Immatics Chief Development Officer, Dr Carsten Reinhardt joins the board to boost global development of Theolytics oncolytic viral technology

Upcoming Events

PULSE Check – IP considerations for start ups and spin outs

Wednesday, 28 October 2020, 4pm to 7pm

Do you have questions about how to best protect your IP? Do you have questions about funding for IP? This session will be run by Maucher Jenkins in association with the BIA, and will address issues around early-stage IP.

Digital BioTuesday: 'An Insight to the Role of Biobanks in Life Sciences R&D Innovation'

Tuesday, 03 November 2020, 5pm to 6.30pm

This BioTuesday event, kindly hosted by The Oxford Science Park, will bring together experts from across the biobanking industry, to share an update on how biobanks have evolved, common goals between partners and the potential impact on future research.

Women in Healthcare Innovation - The Hill

Saturday, 07 November 2020, 9am to 4.30pm

Join The Hill for a day of online workshops and panel discussions with entrepreneurial women experts in the Oxford healthcare innovation ecosystem.

Bio Integrates 2020

Monday, 16 November 2020

Addressing the needs of innovative companies developing the therapies of tomorrow, Bio Integrates provides a unique forum to discuss the major challenges impacting the sector, and the opportunity to engage with top executives in biotech, CDMO, supply chain, and funding and investment.

BioEscalator Team
Photograph of the BioEscalator building and adjoining carpark, taken from the top of the Kennedy building © BioEscalator Oxford